Coloplast Names Gavin Wood as CEO

Copenhagen, March 4, 2026 (Coloplast) -- Coloplast has appointed Gavin Wood as President and Chief Executive Officer, effective May 1, 2026, succeeding interim CEO Lars Rasmussen. Wood joins after more than 20 years at Johnson & Johnson, most recently serving as Company Group Chairman of Johnson & Johnson MedTech EMEA, overseeing a multi-billion-dollar business spanning surgery, orthopedics, and cardiovascular solutions. He will relocate to Denmark as he takes over leadership of the Danish medical device company and advances its Impact4 growth strategy.

Read full article here.